• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌组织中高 visfatin 表达与不良预后相关。

High visfatin expression in breast cancer tissue is associated with poor survival.

机构信息

Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1892-901. doi: 10.1158/1055-9965.EPI-11-0399. Epub 2011 Jul 22.

DOI:10.1158/1055-9965.EPI-11-0399
PMID:21784959
Abstract

BACKGROUND

Adipocytokines, adipocyte-secreted hormones, play a critical role in breast cancer development. The expression of visfatin, a newly discovered adipocytokine, in breast cancer tissues was determined and correlated with patient clinicopathologic variables.

METHODS

Visfatin expression in breast cancer tissues was analyzed by immunohistochemistry. Visfatin expression was correlated with clinicopathologic variables as well as recurrence rates, using the χ(2) test. The prognostic value of visfatin for disease-free and overall survival was evaluated by Kaplan-Meier estimates, and the significance of differences between curves was evaluated by the log-rank test.

RESULTS

High visfatin expression in breast cancer tissues was significantly correlated with tumor size, estrogen receptor (ER) negativity, and progesterone receptor (PR) negativity. Hormone therapy, but not radiotherapy or chemotherapy, decreased the recurrence rate in patients with high visfatin expression. Whereas high visfatin expression alone was associated with poor disease-free and overall survival, worse disease-free and overall survival was observed when high visfatin expression was combined with ER- and PR-negative status. Cox regression analysis also revealed that visfatin is an independent predictor of disease-free and overall survival.

CONCLUSION

High visfatin expression in breast cancer tissue is associated with more malignant cancer behavior as well as poor patient survival.

IMPACT

Visfatin is an independent prognosis predictor for breast cancer.

摘要

背景

脂肪细胞因子是脂肪细胞分泌的激素,在乳腺癌的发生发展中起着关键作用。本研究通过免疫组化的方法检测了一种新发现的脂肪细胞因子内脂素在乳腺癌组织中的表达情况,并分析了它与患者临床病理参数的关系。

方法

应用免疫组化方法检测乳腺癌组织中内脂素的表达情况,采用卡方检验分析内脂素的表达与临床病理参数及复发率的关系。Kaplan-Meier 法进行生存分析,log-rank 检验比较组间差异。

结果

乳腺癌组织中内脂素的高表达与肿瘤大小、雌激素受体(ER)阴性和孕激素受体(PR)阴性相关。激素治疗而非放疗或化疗能降低内脂素高表达患者的复发率。尽管内脂素高表达本身与无病生存率和总生存率降低有关,但当内脂素高表达与 ER 和 PR 阴性状态相结合时,无病生存率和总生存率更差。Cox 回归分析也显示内脂素是无病生存率和总生存率的独立预测因子。

结论

乳腺癌组织中内脂素的高表达与更具侵袭性的肿瘤行为及较差的患者生存率相关。

意义

内脂素是乳腺癌的独立预后预测因子。

相似文献

1
High visfatin expression in breast cancer tissue is associated with poor survival.乳腺癌组织中高 visfatin 表达与不良预后相关。
Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1892-901. doi: 10.1158/1055-9965.EPI-11-0399. Epub 2011 Jul 22.
2
Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification.乳腺癌组织中抵抗素表达作为预后和激素治疗分层的标志物。
Gynecol Oncol. 2012 Jun;125(3):742-50. doi: 10.1016/j.ygyno.2012.02.032. Epub 2012 Feb 24.
3
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.LEA-135表达:其与淋巴结阳性原发性浸润性乳腺癌患者较低的复发风险及总生存期延长的相关性。
Anticancer Res. 2004 Jul-Aug;24(4):2391-400.
4
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.孕激素受体是与乳腺癌患者临床结局和辅助他莫昔芬治疗效果相关的重要因素。
Breast Cancer Res Treat. 2010 Jan;119(1):53-61. doi: 10.1007/s10549-009-0318-0. Epub 2009 Feb 10.
5
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.NDRG1 和 SPARC 蛋白表达在乳腺癌患者中的预后价值。
Breast Cancer Res Treat. 2011 Feb;126(1):1-14. doi: 10.1007/s10549-010-0867-2. Epub 2010 Apr 6.
6
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.高危早期乳腺癌中雌激素受体、孕激素受体和微管相关蛋白Tau的基因表达:在希腊合作肿瘤学组试验背景下寻找治疗获益的分子预测指标
Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31.
7
Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.丝裂原活化蛋白激酶(MAPK)表达水平较低与激素受体阴性乳腺癌患者的蒽环类耐药及生存率降低有关。
Cancer Invest. 2008 Aug;26(7):671-9. doi: 10.1080/07357900801891628.
8
Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.p53、bcl-2和Bax表达在早期乳腺癌中的预后意义。
J Am Coll Surg. 2004 Jan;198(1):83-90. doi: 10.1016/j.jamcollsurg.2003.08.008.
9
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.通过联合评估p53和前列腺特异性抗原的表达增强乳腺癌预后预测
Br J Cancer. 1999 Oct;81(3):490-5. doi: 10.1038/sj.bjc.6690720.
10
Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.人表皮生长因子受体2阴性乳腺癌标本中趋化因子受体CXCR4水平升高预示复发。
J Surg Res. 2007 Jul;141(1):53-9. doi: 10.1016/j.jss.2007.03.015.

引用本文的文献

1
Exploring the multifaceted role of obesity in breast cancer progression.探索肥胖在乳腺癌进展中的多方面作用。
Front Cell Dev Biol. 2024 Jul 8;12:1408844. doi: 10.3389/fcell.2024.1408844. eCollection 2024.
2
The Role of Adipokines in Health and Disease.脂肪因子在健康与疾病中的作用
Biomedicines. 2023 Apr 27;11(5):1290. doi: 10.3390/biomedicines11051290.
3
Comparison of visfatin levels in patients with breast cancer and endometrial cancer with healthy individuals: A systematic review and meta-analysis.乳腺癌和子宫内膜癌患者与健康个体内脂素水平的比较:一项系统评价与荟萃分析。
Health Sci Rep. 2022 Nov 18;5(6):e895. doi: 10.1002/hsr2.895. eCollection 2022 Nov.
4
Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer.肿瘤微环境中脂肪因子表达的改变促进三阴性乳腺癌的发展。
Cancers (Basel). 2022 Aug 26;14(17):4139. doi: 10.3390/cancers14174139.
5
QPRT Acts as an Independent Prognostic Factor in Invasive Breast Cancer.QPRT是浸润性乳腺癌的独立预后因素。
J Oncol. 2022 Feb 24;2022:6548644. doi: 10.1155/2022/6548644. eCollection 2022.
6
Association between Tumor Prognosis Marker Visfatin and Proinflammatory Cytokines in Hypertensive Patients.高血压患者中肿瘤预后标志物内脂素与促炎细胞因子的关系。
Biomed Res Int. 2021 Mar 16;2021:8568926. doi: 10.1155/2021/8568926. eCollection 2021.
7
Quinolinate Phosphoribosyltransferase Promotes Invasiveness of Breast Cancer Through Myosin Light Chain Phosphorylation.喹啉酸磷酸核糖基转移酶通过肌球蛋白轻链磷酸化促进乳腺癌的侵袭性。
Front Endocrinol (Lausanne). 2021 Feb 4;11:621944. doi: 10.3389/fendo.2020.621944. eCollection 2020.
8
Molecular insights into the interplay between adiposity, breast cancer and bone metastasis.肥胖、乳腺癌与骨转移之间相互作用的分子见解。
Clin Exp Metastasis. 2021 Apr;38(2):119-138. doi: 10.1007/s10585-021-10076-0. Epub 2021 Feb 16.
9
Visfatin Enhances Breast Cancer Progression through CXCL1 Induction in Tumor-Associated Macrophages.内脂素通过诱导肿瘤相关巨噬细胞产生CXCL1促进乳腺癌进展。
Cancers (Basel). 2020 Nov 26;12(12):3526. doi: 10.3390/cancers12123526.
10
Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue.肥胖与乳腺癌:一例炎症性脂肪组织病例
Cancers (Basel). 2020 Jun 25;12(6):1686. doi: 10.3390/cancers12061686.